Separate goals, converging priorities: On the ethics of treatment as prevention

Developing World Bioethics

Volumn 13, Issue 2, 2013, Pages 57-62

  Ostmann, Florian ^a   Saenz, Carla ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antiretroviral therapy; Bioethics; HIV AIDS; Prevention; Priority setting; Treatment; Treatment as prevention

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY; ARTICLE; BIOETHICS; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRY; DISEASE TRANSMISSION; ETHICS; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HIV/AIDS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; MOTIVATION; PREVENTION; PRIMARY PREVENTION; PRIORITY SETTING; TREATMENT; TREATMENT AS PREVENTION; VERTICAL TRANSMISSION;

ANTIRETROVIRAL THERAPY; BIOETHICS; HIV/AIDS; PREVENTION; PRIORITY SETTING; TREATMENT; TREATMENT AS PREVENTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GOALS; HEALTH CARE RATIONING; HEALTH PRIORITIES; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PRIMARY PREVENTION;

EID: 84880693576     PISSN: 14718731     EISSN: 14718847     Source Type: Journal    
DOI: 10.1111/dewb.12021     Document Type: Article

References (25)

1. D.W. Brock & D. Wikler. Ethical Challenges in Long-Term Funding for HIV/AIDS. Health Aff 2009; 28: 1666-1676.
2. G. Pantaleo, C. Graziosi & A.S. Fauci. The Immunopathogenesis of Human Immunodeficiency Virus Infection. N Engl J Med 1993; 328: 327-335.
3. World Health Organization (WHO). 2007. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: WHO. Available at: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf [Accessed 26 Jan 2013].
4. World Health Organization (WHO). 2012. Antiretroviral Treatment as Prevention (TASP) of HIV and TB: Programmatic Update. Geneva: WHO. Available at: http://whqlibdoc.who.int/hq/2012/WHO_HIV_2012.12_eng.pdf [Accessed 26 Jan 2013].
5. M.S. Cohen etal. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Engl J Med 2011; 365: 493-505.
6. WHO, op. cit. note.
7. WHO, op. cit. note.
8. R.M. Granich etal. Universal Voluntary HIV Testing with Immediate Antiretroviral Therapy as a Strategy for Elimination of HIV Transmission: A Mathematical Model. Lancet 2009; 373: 48-57.
9. Cohen etal., op cit. note
10. D. Donnell etal. Heterosexual HIV-1 Transmission after Initiation of Antiretroviral Therapy: A Prospective Cohort Analysis. Lancet 2010; 375: 2092-2098
11. F. Tanser etal. 2012. Effect of ART Coverage on Rate of New HIV Infections in a Hyper-endemic, Rural Population: South Africa. Abstract presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA.
12. H. Jaffe & T. Hope. Treating for the Common Good: A Proposed Ethical Framework. Public Health Ethics 2012; 3: 193-198.
13. R. Macklin & E. Cowan. Given Financial Constraints, It Would Be Unethical to Divert Antiretroviral Drugs from Treatment to Prevention. Health Aff 2012; 31: 1537-1543: 1542.
14. WHO, op. cit. note.
15. Pantaleo, Graziosi & Fauci. op. cit. note.
16. T.D. Hollingsworth, R.M. Anderson & C. Fraser. HIV-1 Transmission, by Stage of Infection. J Infect Dis 2008; 198: 687-693.
17. L.H. Bachman, etal. Sexually Transmitted Disease/HIV Transmission Risk Behaviors and Sexually Transmitted Disease Prevalence Among HIV-Positive Men Receiving Continuing Care. Sex Transm Dis 2005; 32: 20-26;
18. L.A. Eaton & S.C. Kalichman. Changes in Transmission Risk Behaviors across Stages of HIV Disease among People Living With HIV. J Assoc Nurses AIDS Care 2009; 20: 39-49
19. B.L. Rapatski, F. Suppe & J.A. Yorke. HIV Epidemics Driven by Late Disease Stage Transmission. J Acquir Immune Defic Syndr 2005; 38: 241-253.
20. Hollingsworth, Anderson & Fraser. op. cit. note
21. Rapatski, Suppe & Yorke. op. cit. note
22. Brock & Wikler. op. cit. note
23. B. Haire. Treatment-as-Prevention Needs to Be Considered in the Just Allocation of HIV Drugs. Am J Bioeth 2011; 11(12): 48-50.
24. Brock & Wikler. op. cit. note
25. P. Singer. Famine, Affluence and Morality. Philos Public Aff 1972; 1: 229-243.